AusperBio

/
/
AusperBio
Biotech Clinical Procurement
AusperBio is a clinical-stage biopharmaceutical company focused on developing innovative therapies for oncology and autoimmune diseases. The company operates R&D centers in Shanghai, China, and the United States, and is committed to advancing drug development through cutting-edge scientific research to deliver breakthrough treatments for patients worldwide.
Project Introduction
The development of innovative oncology therapies requires strengthened global supply chain and cash management capabilities. This project integrates multi-country financial consolidation, CRO procurement contract management, and direct connectivity with SVB and Chase banks, enabling standardized procurement, automated cash flow management, and refined inventory control—supporting the efficient execution of global multi-center clinical trials.
Solutions
Multi-Country Financial Consolidation CRO Procurement Contract Management End-to-End Procure-to-Pay Process Control SVB/Chase Bank Integration Fixed Asset Management Inventory Management – Refined Control
Project Benefits
Global Financial Integration Standardized Clinical Procurement Automated Cash Management Significant Improvement in Operational Efficiency